(Q34023798)

30 July 2017

1 reference

title

Protein tyrosine phosphatase-1B in diabetes (English)

1 reference

30 July 2017

Kennedy BP

1

1 reference

PubMed ID

10974195

30 July 2017

Ramachandran C

series ordinal

2

1 reference

PubMed ID

10974195

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

Biochemical Pharmacology

1 reference

30 July 2017

60

1 reference

30 July 2017

877-883

1 reference

30 July 2017

7

1 reference

The insulin signaling pathway

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Abnormal Regulation of Protein Tyrosine Phosphatase Activities in Skeletal Muscle of Insulin-Resistant Humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein tyrosine phosphatases: their role in insulin action and potential as drug targets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Lymphocyte activation: the coming of the protein tyrosine phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein-tyrosine phosphatases: biological function, structural characteristics, and mechanism of catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein tyrosine phosphatases in signal transduction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Combination of gene targeting and substrate trapping to identify substrates of protein tyrosine phosphatases using PTP-PEST as a model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Neuroendocrine dysplasia in mice lacking protein tyrosine phosphatase sigma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Impaired bone marrow microenvironment and immune function in T cell protein tyrosine phosphatase-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Impaired mammary gland development and function in mice lacking LAR receptor-like tyrosine phosphatase activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Transgenic mice deficient in the LAR protein-tyrosine phosphatase exhibit profound defects in glucose homeostasis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Expression of protein-tyrosine phosphatases in the major insulin target tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein tyrosine phosphatase 1B interacts with and is tyrosine phosphorylated by the epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein tyrosine phosphatase 1B interacts with the activated insulin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Sequential dephosphorylation of a multiply phosphorylated insulin receptor peptide by protein tyrosine phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

The nontransmembrane tyrosine phosphatase PTP-1B localizes to the endoplasmic reticulum via its 35 amino acid C-terminal sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Insulin receptor-associated protein tyrosine phosphatase(s): role in insulin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Deconstructing type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Insulin resistance and antidiabetic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Closing in on the cause of insulin resistance and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Insulin action impaired by deficiency of the G-protein subunit G ialpha2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Vanadate normalizes hyperglycemia in two mouse models of non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Insulin resistance is associated with abnormal dephosphorylation of a synthetic phosphopeptide corresponding to the major autophosphorylation sites of the insulin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Increased abundance of specific skeletal muscle protein-tyrosine phosphatases in a genetic model of insulin-resistant obesity and diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Decreased skeletal muscle phosphotyrosine phosphatase (PTPase) activity towards insulin receptors in insulin-resistant Zucker rats measured by delayed Europium fluorescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Differential effects of diabetes on adipocyte and liver phosphotyrosine and phosphoserine phosphatase activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Differential regulation of multiple hepatic protein tyrosine phosphatases in alloxan diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Insulin receptor dephosphorylation by phosphotyrosine phosphatases obtained from insulin-resistant obese mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Skeletal muscle protein tyrosine phosphatase activity and tyrosine phosphatase 1B protein content are associated with insulin action and resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Marked impairment of protein tyrosine phosphatase 1B activity in adipose tissue of obese subjects with and without type 2 diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Identification of an obesity quantitative trait locus on mouse chromosome 2 and evidence of linkage to body fat and insulin on the human homologous region 20q.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Genome scan for human obesity and linkage to markers in 20q13.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Molecular cloning and chromosome mapping of the human gene encoding protein phosphotyrosyl phosphatase 1B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Obesity, diabetes and the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Vanadate stimulates in vivo glucose uptake in brain and arrests food intake and body weight gain in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein tyrosine phosphatases: counting the trees in the forest

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Mechanism of inhibition of protein-tyrosine phosphatases by vanadate and pervanadate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Visualization of intermediate and transition-state structures in protein-tyrosine phosphatase catalysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Vanadate inhibition of protein tyrosine phosphatases in Jurkat cells: modulation by redox state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

7 January 2021

Vanadium and diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Thiophosphorylated substrate analogs are potent active site-directed inhibitors of protein-tyrosine phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Inhibition of protein tyrosine phosphatases PTP1B and CD45 by sulfotyrosyl peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Potent inhibition of insulin receptor dephosphorylation by a hexamer peptide containing the phosphotyrosyl mimetic F2Pmp

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Why is phosphonodifluoromethyl phenylalanine a more potent inhibitory moiety than phosphonomethyl phenylalanine toward protein-tyrosine phosphatases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein-tyrosine phosphatase inhibition by a peptide containing the phosphotyrosyl mimetic, L-O-malonyltyrosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Protein tyrosine phosphatase substrate specificity: size and phosphotyrosine positioning requirements in peptide substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Affinity selection from peptide libraries to determine substrate specificity of protein tyrosine phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

An immunological approach reveals biological differences between the two NDF/heregulin receptors, ErbB-3 and ErbB-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Phosphonate inhibitors of protein-tyrosine and serine/threonine phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Small molecule interactions with protein-tyrosine phosphatase PTP1B and their use in inhibitor design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Potent non-peptidyl inhibitors of protein tyrosine phosphatase 1B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Naphthalenebis[alpha,alpha-difluoromethylenephosphonates] as potent inhibitors of protein tyrosine phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Novel phosphate mimetics for the design of non-peptidyl inhibitors of protein tyrosine phosphatases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Potent and highly selective inhibitors of the protein tyrosine phosphatase 1B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

PTP1B inhibition and antihyperglycemic activity in the ob/ob mouse model of novel 11-arylbenzo[b]naphtho[2,3-d]furans and 11-arylbenzo[b]naphtho[2,3-d]thiophenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

Intraventricular insulin reduces food intake and body weight of lean but not obese Zucker rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900305-1

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-2952(00)00305-1

1 reference

30 July 2017

1 reference

PubMed ID

10974195